News
AI will deliver transformative therapies at an exponential scale, addressing the complexities of biology that traditional ...
Pharmaceutical rivals don’t often come to each other’s defense. But after the US Department of Health and Human Services ...
Amid industry-wide shifts, Salesforce adjusts its workforce strategy, reallocating roles and prioritizing sales hires, as AI ...
Inovio Pharmaceuticals Inc. closed 83.78% short of its 52-week high of $12.33, which the company reached on July 26th.
In the dynamic world of life sciences, companies face unique challenges in safeguarding their valuable assets. From ...
Francis Samaan’s body is in Jordan, but his heart is in Sudan. The third-year theology student sits in a quiet commons area ...
Ivonescimab helped cut the risk of lung tumor progression in half in a multi-country Phase 3 trial. But it hasn’t yet clearly ...
Cancer remains one of the biggest health challenges of our lifetime. Millions of people globally receive a cancer diagnosis each year — in the United States, that’s about one diagnosis every 30 ...
10h
Zacks Investment Research on MSNHere's Why You Should Add Cencora Stock to Your Portfolio NowCencora, Inc. COR is well-poised for growth on the back of a robust U.S. Healthcare Solutions business and product launches.
Take a closer look at London's biotech hub – renowned for its thriving life sciences ecosystem and world-class infrastructure ...
Generation Investment Management, an investment management firm, released its “Global Equity Strategy” first quarter 2025 ...
From five years of sales declines to nine consecutive quarters of growth, it’s hard to deny that Teva’s revamp under CEO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results